Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 123.61B | 124.76B | 119.82B | 122.00B | 121.93B | 138.49B |
Gross Profit | 25.09B | 25.22B | 22.36B | 21.31B | 25.66B | 22.22B |
EBITDA | 12.32B | 19.54B | 10.80B | 8.23B | 12.72B | 9.75B |
Net Income | 10.07B | 10.29B | 3.66B | 2.01B | 6.17B | 6.34B |
Balance Sheet | ||||||
Total Assets | 197.52B | 196.78B | 194.85B | 192.76B | 196.71B | 197.72B |
Cash, Cash Equivalents and Short-Term Investments | 21.32B | 24.25B | 23.58B | 24.76B | 26.35B | 36.65B |
Total Debt | 20.98B | 21.04B | 25.28B | 31.00B | 32.91B | 42.70B |
Total Liabilities | 69.58B | 66.28B | 75.69B | 78.47B | 86.22B | 94.06B |
Stockholders Equity | 125.68B | 128.01B | 116.75B | 112.06B | 108.45B | 101.90B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -1.27B | 4.48B | -2.24B | -252.00M | 4.26B |
Operating Cash Flow | 0.00 | 4.17B | 9.02B | 3.00B | 7.58B | 11.52B |
Investing Cash Flow | 0.00 | 1.42B | -1.45B | -2.19B | -6.64B | -3.77B |
Financing Cash Flow | 0.00 | -7.00B | -10.21B | -3.84B | -11.42B | -358.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥62.87B | 8.25 | 2.06% | 5.44% | 8.53% | ||
79 Outperform | ¥56.91B | 5.28 | 4.74% | 4.12% | 192.18% | ||
77 Outperform | ¥58.46B | 14.31 | 3.00% | 6.36% | 17.44% | ||
74 Outperform | ¥81.99B | 9.33 | 4.14% | 4.87% | 5.07% | ||
71 Outperform | ¥45.51B | 8.73 | 5.37% | 3.16% | ― | ||
66 Neutral | ¥60.26B | 9.69 | 4.58% | 3.21% | -2.40% | ||
44 Neutral | C$982.42M | -6.71 | -13.24% | 2.54% | 17.20% | -32.72% |